Deferasirox treatment may be associated with reversible renal Fanconi syndrome.
Even-Or
Ehud
E
Becker-Cohen
Rachel
R
Miskin
Hagit
H
D000293:Adolescent; D001565:Benzoates / Q000008:administration & dosage*; D002648:Child; D000077588:Deferasirox; D005198:Fanconi Syndrome / Q000628:therapy* / Q000652:urine; D005260:Female; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology / Q000652:urine; D007668:Kidney / Q000378:metabolism; D008297:Male; D065227:Transfusion Reaction; D014230:Triazoles / Q000008:administration & dosage*
D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox